What is the current stock price of Evolutionary Genomics, Inc. (FNAM)?

As of the latest market data, Evolutionary Genomics, Inc. (FNAM) is trading at $0.00. The stock has seen a loss of 0.00% today.

Does Evolutionary Genomics, Inc. (FNAM) pay a dividend?

Based on current data, Evolutionary Genomics, Inc. does not have a confirmed active dividend policy.

What is the market cap of Evolutionary Genomics, Inc.?

The current market capitalization of Evolutionary Genomics, Inc. (FNAM) is approximately unavailable.

FNAM

Evolutionary Genomics, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.45

Company Profile

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2012-05-15

Beta

-0.15

Websitewww.evolgen.com↗